In Vitro Diagnostics Market is Expected to Reach USD 74.2 Billion Globally in 2018: Transparency Market Research

Transparency Market Research published new market report "In Vitro Diagnostics Market (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics)- Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018," market was valued at USD 46.0 billion in 2011 and is expected to reach an estimated value of USD 74.2 billion in 2018, growing at a CAGR of 7.1% from 2012 to 2018.

Buy full report at http://www.transparencymarketresearch.com/in-vitro-diagnostic-tests.html

In vitro diagnostics (IVDs) provide valuable information regarding the physiological and/or pathological state of body and therefore are very essential to take well-informed medical decisions. Rising number of patients suffering from infectious and chronic diseases such as sexually transmitted diseases, chronic obstructive pulmonary disease, diabetes and cancer is the most significant growth driver of this market. In addition, factors such as increasing global healthcare expenditure and demand for rapid, minimally invasive and non-invasive diagnostic tools & techniques are driving the market as well.

In 2011, the North America IVD market held the second largest share of the global market at approximately 40%. The Asia-Pacific IVD market is expected to outperform all geographies in terms of growth rate during the forecast period. Presence of large patient pool and rising healthcare expenditure in these regions are responsible for this growth.

The clinical chemistry segment of the market held the largest market share across all major geographic regions such as the U.S., China and India in 2011. However, increase in demand for molecular diagnostics in the IVD market is expected to cut into the market share of clinical chemistry by 2018.

In 2011, Roche Diagnostics (Roche Group) held the largest share in the global in vitro diagnostics market followed by Siemens Healthcare (Siemens AG). Some of the other major companies involved in the development, manufacturing and distribution of in vitro diagnostics are Johnson & Johnson, Beckman Coulter Inc., Becton Dickinson and Company, Gen-Probe Incorporated and Thermo Fisher Scientific Corporation.

The global in vitro diagnostics market is categorized into the following segments:

Market by Products

• U.S.
• Clinical Chemistry
• Immunoassay
• Diabetes Testing
• Blood Testing
• Molecular Diagnostics
• Others (Flow Cytometry, Microbiological Diagnostic Techniques)

• India
• Clinical Chemistry
• Immunoassay
• Diabetes Testing
• Blood Testing
• Molecular Diagnostics
• Others (Flow Cytometry, Microbiological Diagnostic Techniques)

• China
• Clinical Chemistry
• Immunoassay
• Diabetes Testing
• Blood Testing
• Molecular Diagnostics
• Others (Flow Cytometry, Microbiological Diagnostic Techniques)

Market by Geography

• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

TABLE OF CONTENTS

Chapter 1 Preface

1.1 Report Description

1.2 Research Methodology

1.3 Market Segmentation

Chapter 2 Executive Summary

Chapter 3 Market Overview

3.1 Market Trend and Future Outlook

       3.1.1 Global In Vitro Diagnostics Market, 2010 – 2018 (USD Million)

3.2 Market Dynamics

       3.2.1 Market drivers

                3.2.1.1 Rising Number of Patients with Infectious and Chronic Diseases

                3.2.1.2 Increasing Global Healthcare Expenditure

                3.2.1.3 Demand for Rapid and Minimally- or Non-Invasive Diagnostic Tools & Techniques

                3.2.1.4 Impact Analysis of the Market Drivers

       3.2.2 Market Restraints

                3.2.2.1 Reimbursement Challenges Retards the Growth of Market

                3.2.2.2 Uncertain and Ambiguous Regulatory environment restrains In Vitro Diagnostics market

                3.2.2.3 Impact Analysis of the Market Restraints

       3.2.3 Market Opportunities

                3.2.3.1 Molecular Diagnostics: Key to Future

                3.2.3.2 Epigenomics-Based Diagnostics expected to be an Emerging segment in In-Vitro Diagnostic Market

       3.2.4 Porter’s Five Forces Analysis for In Vitro Diagnostic Market

                3.2.4.1 Bargaining Power of Suppliers

                3.2.4.2 Bargaining Power of Buyers

                3.2.4.3 Threat of new entrants

                3.2.4.4 Threat of substitutes

       3.2.5 Competitive rivalry

3.3 Market Attractiveness Analysis of the Global In-Vitro Diagnostics Market, by Geography

Chapter 4 Global In Vitro Diagnostics Market, by Products (Qualitative information)

4.1 Overview

4.2 Clinical Chemistry

4.3 Immunoassay

4.4 Diabetes Testing

4.5 Blood Testing

4.6 Molecular Diagnosis

4.7 Others

Chapter 5 Global In Vitro Diagnostics Market, by Geography

5.1 Overview

5.2 North America

       5.2.1 North America In Vitro Diagnostics Market, 2010-2018 (USD Million)

5.3 Europe

       5.3.1 Europe In Vitro Diagnostics Market, 2010-2018 (USD Million)

5.4 Asia Pacific

       5.4.1 Asia Pacific In Vitro Diagnostics Market, 2010-2018 (USD Million)

5.5 Rest of the World

       5.5.1 ROW In Vitro Diagnostics Market, 2010-2018 USD Million)

Chapter 6 U.S. In Vitro Diagnostics Market, by Products

6.1 Overview

6.2 Clinical Chemistry IVD Market, 2010 – 2018 (USD Million)

6.3 Immunoassay IVD Market, 2010 – 2018 (USD Million)

6.4 Diabetes Testing IVD Market, 2010 – 2018 (USD Million)

6.5 Blood Testing IVD Market, 2010 – 2018 (USD Million)

6.6 Molecular Diagnosis IVD Market, 2010 – 2018 (USD Million)

6.7 Others IVD Market, 2010 – 2018 (USD Million)

Chapter 7 China In Vitro Diagnostics Market, by Products

7.1 Overview

7.2 Clinical Chemistry IVD Market, 2010 – 2018 (USD Million)

7.3 Immunoassay IVD Market, 2010 – 2018 (USD Million)

7.4 Diabetes Testing IVD Market, 2010 – 2018 (USD Million)

7.5 Blood Testing IVD Market, 2010 – 2018 (USD Million)

7.6 Molecular Diagnosis IVD Market, 2010 – 2018 (USD Million)

7.7 Others IVD Market, 2010 – 2018 (USD Million)

Chapter 8 India In Vitro Diagnostics Market, by Products

8.1 Overview

8.2 Clinical Chemistry IVD Market, 2010 – 2018 (USD Million)

8.3 Immunoassay IVD Market, 2010 – 2018 (USD Million)

8.4 Diabetes Testing IVD Market, 2010 – 2018 (USD Million)

8.5 Blood Testing IVD Market, 2010 – 2018 (USD Million)

8.6 Molecular Diagnosis IVD Market, 2010 – 2018 (USD Million)

8.7 Others IVD Market, 2010 – 2018 (USD Million)

Chapter 9 Competitive Landscape

9.1 Global In Vitro Diagnostics Market Share, by Key Players, 2011 (%)

Chapter 10 Company Profiles

10.1 Abbott Laboratories Inc. 

       10.1.1 Company Overview

       10.1.2 Financial overview

       10.1.3 Business Strategies

       10.1.4 Product Portfolio

       10.1.5 Recent Developments

10.2 Alere, Inc.

       10.2.1 Company Overview

       10.2.2 Financial Overview

       10.2.3 Business Strategies

       10.2.4 Product Portfolio

       10.2.5 Recent Developments

10.3 Bayer AG

       10.3.1 Company Overview

       10.3.2 Financial Overview

       10.3.3 Business Strategies

       10.3.4 Product Portfolio

       10.3.5 Recent Developments

10.4 Becton, Dickinson and Company

       10.4.1 Company Overview

       10.4.2 Financial Overview

       10.4.3 Business Strategies

       10.4.4 Product Portfolio

       10.4.5 Recent Developments

10.5 Biomerieux SA

       10.5.1 Company Overview

       10.5.2 Financial Overview

       10.5.3 Business Strategies

       10.5.4 Product Portfolio

       10.5.5 Recent Developments

10.6 Beckman Coulter, Inc.

       10.6.1 Company Overview

       10.6.2 Financial overview

       10.6.3 Business Strategies

       10.6.4 Product portfolio

       10.6.5 Recent developments

10.7 Gen-Probe Incorporated

       10.7.1 Company Overview

       10.7.2 Financial Overview

       10.7.3 Business Strategies

       10.7.4 Product Portfolio

       10.7.5 Recent Developments

10.8 Johnson and Johnson

       10.8.1 Company Overview

       10.8.2 Financial Overview

       10.8.3 Business Strategies

       10.8.4 Product Portfolio

       10.8.5 Recent Developments

10.9 Life Technologies Corporation

       10.9.1 Company Overview

       10.9.2 Financial Overview

       10.9.3 Business Strategies

       10.9.4 Product Portfolio

       10.9.5 Recent Development

10.10 F. Hoffmann-La Roche Ltd

       10.10.1 Company Overview

       10.10.2 Financial Overview

       10.10.3 Business strategies

       10.10.4 Product portfolio

       10.10.5 Recent developments

10.11 Siemens Healthcare

       10.11.1 Company Overview

       10.11.2 Financial Overview

       10.11.3 Business Strategies

       10.11.4 Product Portfolio

       10.11.5 Recent Developments

10.12 Thermo Fisher Scientific, Inc.

       10.12.1 Company Overview

       10.12.2 Financial overview

       10.12.3 Business strategies

       10.12.4 Product portfolio

       10.12.5 Recent developments

 Browse the full report With TOC at http://www.transparencymarketresearch.com/in-vitro-diagnostic-tests.html

About Us:

Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact:

Transparency Market Research

90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/